medline.ch Onkologie Urologische Tumoren

	Diagnosis of prostate cancer by multi-modal ultrasound imaging. Medicine (Baltimore) Li J, He K, Zhang H, Hu D, Wei X, Luo L. PMID: 42888615 [PubMed - indexed for MEDLINE]
	Development and validation of a ferroptosis and metabolic reprogramming gene signature for risk stratification in bladder urothelial carcinoma: A retrospective multicohort study. Medicine (Baltimore) Ma Y, Zhang Z, Tang L, Li Q, Zhao Y. PMID: 42888597 [PubMed - indexed for MEDLINE]
	Investigation on Automatic Classification of Bone, Lymph Node, and Local Lesions in CT Images of Prostate Cancer Patients. J Imaging Inform Med Rainio O, Vehmanen A, Li A, Jaakkola MK, Kemppainen J, Klén R. PMID: 42888311 [PubMed - as supplied by publisher]
	Active Surveillance for Intermediate-risk Prostate Cancer: Implications of AI-enabled Pattern Quantification. Eur Urol Focus Mittmann G, van den Bergh RCN, Fine SW, Vickers AJ, Brinker TJ. PMID: 42888115 [PubMed - as supplied by publisher]
	MicroRNAs in prostate cancer radioresistance: mechanisms, target-based network analysis and translational opportunities. Exp Mol Pathol Ferreira I, Ferreira M, Medeiros R, Teixeira AL. PMID: 42887484 [PubMed - as supplied by publisher]
	Plasma-Derived Genomic Instability Status and Rucaparib Outcomes in Metastatic Castration-Resistant Prostate Cancer: TRITON2. JCO Precis Oncol Abida W, Bryce AH, Chowdhury S, Patnaik A, Overstreet B, Margolis M, Safabakhsh P, Fizazi K. PMID: 42886888 [PubMed - indexed for MEDLINE]
	Management of extravasations of enfortumab vedotin and pembrolizumab: a case report and mini review of the current literature. J Cancer Res Clin Oncol Dinkel H, Seifert KE, Bögemann M, Schrader AJ, Schlack K. PMID: 42886339 [PubMed - indexed for MEDLINE]
	Risk-adapted MRI Protocols for the Detection of Clinically Significant Prostate Cancer. Radiol Imaging Cancer Ponsiglione A, Cereser L, De Martino M, Bacchetti E, Cirillo M, Cuocolo R, Di Costanzo G, Stanzione A, Brembilla G, Pecoraro M, Dias AB, Gutierrez PA, Hernández-Mancera J, Messina E, Russo L, Cannella R, Ascione R, Borgheresi A, Zuiani C, Crestani A, Giannarini G, Panebianco V, Padhani AR, Imbriaco M, Girometti R. PMID: 42886040 [PubMed - indexed for MEDLINE]
	Enhanced detection of bladder cancer using machine learning analysis of routine urinary sediment data. Clin Chem Lab Med Okuyama R, Horiuchi H, Nakamura M, Muroya M, Morikawa T. PMID: 42885914 [PubMed - as supplied by publisher]
	Effects of Decision Support Interventions on Treatment Decision-Making in Patients With Prostate Cancer: A Systematic Review and Network Meta-Analysis. Asia Pac J Clin Oncol Wen Y, Li Y, Zheng S, Li J, Huang X, Zhang Y, Jin Y. PMID: 42885513 [PubMed - as supplied by publisher]
	General versus site specific quantile random forest models for virtual patient-specific quality assurance of VMAT plans. J Appl Clin Med Phys Rahman N, Kaliel G, D'Souza M, Yamabe Breitkreutz D. PMID: 42885344 [PubMed - indexed for MEDLINE]
	Navigating the landscape of targeted therapies for renal cell carcinoma in the era of precision medicine (Review). Mol Med Rep Cui H, Song J, Yang P, Zhang Z, Liu Y, Zhang G, Tian A, Che J, Liu Y, Sun H, Xu Y. PMID: 42885310 [PubMed - indexed for MEDLINE]
	Soy Consumption and the Risk of Developing Bladder Cancer: A Pooled Analysis of Cohort Studies from the International Pooled Bladder Cancer Epidemiology and Nutritional Determinants (BLEND) Study. Nutrients Wu YW, Yu EY, Chen YT, Li MH, Liang YT. PMID: 42884561 [PubMed - indexed for MEDLINE]
	Urinary DNA Methylation Profiling Identifies a Biologically Distinct Subgroup of Low-Grade Urothelial Carcinoma with High-Grade-Associated Features. Int J Mol Sci Andreu-Inglés M, Onoiu AI, Grifoll-Escoda M, Hernández-Aguilera A, Gumà-Padró J, Riu F, Peña K, Camps J, Parada D. PMID: 42884175 [PubMed - indexed for MEDLINE]
	Gut Microbiota Signatures Associated with Metastatic Prostatic Cancer Treated with Androgen Receptor Pathway Inhibitor (ARPI) Therapy. Int J Mol Sci Pérez-Castro S, Carballo-Quinta M, Rodríguez-Costas N, Freire-Rodríguez A, Davina-Nunez C, Bellas-Pereira A, Taboada-Rodríguez P, Pérez-Schoch M, Cabrera-Alvargonzález JJ, Muller-Arteaga CA, Sánchez-García JF, Cespón-Outeda E, López-Díez ME. PMID: 42883703 [PubMed - indexed for MEDLINE]
	The Enemy of My Enemy: Two Cases of De Novo Metastatic Small-Cell Neuroendocrine Prostate Cancer with BRCA2 Alterations and Brain Metastases. Int J Mol Sci Kjer MF, Poulsen MH, Kjær-Frifeldt S, Holt MI, Vilstrup MH, Zedan AH. PMID: 42883702 [PubMed - indexed for MEDLINE]
	Cytoreductive Radical Prostatectomy in Oligometastatic Prostate Cancer and the Role of the Robotic Platform: A Narrative Review. Cancers (Basel) Rivas JG, Silva PG, Silva HMFSD, Severo L, Pinheiro LC, Romo IG, Redondo-González E, González-Santander C, Sierra JM. PMID: 42882901 [PubMed]
	Consumption of Processed Meat and Unprocessed Red Meat and Risk of Bladder Cancer: A Pooled Analysis of 30 Cohort Studies. Cancers (Basel) Wang Z, Afshar N, Hodge AM, Jayasekara H, Koutros S, van den Brandt PA, Wolk A, Wang M, Hou T, Adami HO, Åkesson A, Arcan C, Bertrand KA, Bittoni M, Bogumil D, Cai H, Cross AJ, Eliassen AH, Freudenheim JL, Gierach GL, Giovannucci EL, Huang WY, Jakszyn P, Kanehara R, Kirsh VA, Koh WP, Kroenke CH, Lacey JV, Liao LM, Loftfield E, Ma C, Marchand LL, Martinez ME, Miller AB, Moore SC, Mucci LA, Munro HM, Neuhouser ML, Petrick JL, Poynter JN, Preston MA, Prizment A, Rees S, Robien K, Rohan TE, Sandin S, Sawada N, Schernhammer ES, Shams-White MM, Shrubsole MJ, Shu XO, Sinha R, Sieri S, Song M, Stampfer MJ, Stolzenberg-Solomon RZ, Triplette M, Um CY, Visvanathan K, VoPham T, Wang F, Wang R, Wang SS, Wang Y, Weiderpass E, Wilkens L, Willett WC, Yuan JM, Zheng W, Rothman N, Lynch BM, Silverman DT, Smith-Warner SA, Milne RL. PMID: 42882897 [PubMed]
	Metabolic Reprogramming in Bladder Cancer: Molecular Drivers, Immune Regulation and Therapeutic Opportunities. Cancers (Basel) Li S, Li M, Zhang Y, Pu J, Sun J, Li C, Guo C. PMID: 42882896 [PubMed]
	Treatment Sequencing in ARPI-Pre-Exposed Metastatic Castration-Resistant Prostate Cancer: Radioligand Therapy, PARP Inhibitors, and Antibody-Drug Conjugates. Cancers (Basel) Sharaf B, Al-Rwashdeh M, El Khatib O, Al-Ibraheem A, Abu Fara A, Ismail A, Alkasrawi H, Abdalla M, Jehad S. PMID: 42882814 [PubMed]

Artikel 1 - 20 / 182231

Seite 1 von 9112

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung